Fagerström Consulting AB, Vaxholm, Sweden.
Nicoventures Limited, London, UK.
Addict Behav. 2014 Mar;39(3):507-11. doi: 10.1016/j.addbeh.2013.11.002. Epub 2013 Nov 10.
Over the last 50 years, the concept of tobacco harm reduction has been well established. It is now understood that nicotine itself is not very harmful and nicotine replacement therapy products have been widely used as an aid to quit, reduce to quit or temporarily abstain from smoking for many years. The popularity of the unlicensed electronic cigarette has increased despite an unknown risk profile and sinus use in Sweden provides strong evidence in support of a harm reduction strategy. The regulatory environment around harm reduction has changed in the UK and is continuing to evolve across the globe. The need for more appealing, licensed nicotine products capable of competing with cigarettes sensorially, pharmacologically and behaviourally is considered by many to be the way forward. The significant positive impact on public health that could be gained from encouraging people to switch from cigarettes to licensed medicinal nicotine products cannot be ignored.
在过去的 50 年里，烟草减害的概念已经得到很好的确立。现在人们已经明白，尼古丁本身的危害并不是很大，而且尼古丁替代疗法产品已经被广泛用作戒烟、减少吸烟或暂时戒烟的辅助手段，已经使用了很多年。尽管非法电子烟的风险状况尚不清楚，但在瑞典，它的使用越来越普遍，这为减害策略提供了强有力的证据。英国围绕减害的监管环境已经发生变化，而且在全球范围内还在继续演变。许多人认为，需要更多有吸引力的、有许可证的尼古丁产品，使其在感官、药理学和行为上能够与香烟竞争，这才是前进的方向。通过鼓励人们从香烟转向有许可证的药用尼古丁产品，可以对公众健康产生重大的积极影响，这一点不容忽视。
